Boston Scientific Corporation $BSX Stock Sold by Illinois Municipal Retirement Fund

Illinois Municipal Retirement Fund lowered its holdings in shares of Boston Scientific Corporation (NYSE:BSX – Free Report) by 27.0% during the 3rd quarter, HoldingsChannel reports. The fund owned 50,945 shares of the medical equipment provider’s stock after selling 18,862 shares during the period. Illinois Municipal Retirement Fund’s holdings in Boston Scientific were worth $2,224,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Clal Insurance Enterprises Holdings Ltd purchased a new position in shares of Boston Scientific during the first quarter valued at approximately $28,000. Cassaday & Co Wealth Management LLC bought a new stake in shares of Boston Scientific in the 1st quarter worth approximately $32,000. Measured Wealth Private Client Group LLC boosted its position in shares of Boston Scientific by 244.9% in the 1st quarter. Measured Wealth Private Client Group LLC now owns 545 shares of the medical equipment provider’s stock worth $34,000 after purchasing an additional 387 shares in the last quarter. Kelleher Financial Advisors purchased a new stake in shares of Boston Scientific in the 2nd quarter worth approximately $25,000. Finally, Nvwm LLC grew its stake in shares of Boston Scientific by 526.2% in the 3rd quarter. Nvwm LLC now owns 645 shares of the medical equipment provider’s stock worth $28,000 after buying an additional 542 shares during the last quarter. Hedge funds and other institutional investors own 89.07% of the company’s stock.

Boston Scientific Price Performance

NYSE BSX opened at $44.33 on Monday. Boston Scientific Corporation has a 52 week low of $39.57 and a 52 week high of $104.61. The firm has a market capitalization of $64.25 billion, a P/E ratio of 18.78, a PEG ratio of 1.31 and a beta of 0.60. The company has a quick ratio of 0.81, a current ratio of 1.36 and a debt-to-equity ratio of 0.42. The company has a 50-day moving average price of $44.00 and a 200-day moving average price of $54.50.

Boston Scientific (NYSE:BSX – Get Free Report) last issued its quarterly earnings data on Wednesday, October 28th. The medical equipment provider reported $0.73 earnings per share for the quarter, hitting the consensus estimate of $0.73. The firm had revenue of $5.14 billion for the quarter, compared to analysts’ expectations of $5.09 billion. Boston Scientific had a net margin of 16.62% and a return on equity of 18.61%. The business’s quarterly revenue was up 1.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.75 EPS. Equities research analysts anticipate that Boston Scientific Corporation will post 3.17 earnings per share for the current year.

Analysts Set New Price Targets

BSX has been the subject of a number of recent research reports. Leerink Partners lowered their price objective on Boston Scientific from $55.00 to $50.00 and set an “outperform” rating for the company in a research note on Thursday, October 29th. TD Cowen cut Boston Scientific from a “buy” rating to a “hold” rating and cut their target price for the stock from $56.00 to $46.00 in a research note on Friday, October 30th. Canaccord Genuity Group reduced their price target on Boston Scientific from $66.00 to $48.00 and set a “buy” rating for the company in a report on Thursday, October 29th. Truist Financial reduced their price target on Boston Scientific from $57.00 to $51.00 and set a “buy” rating for the company in a report on Wednesday, October 14th. Finally, Robert W. Baird lifted their price target on Boston Scientific from $50.00 to $51.00 and gave the stock an “outperform” rating in a research report on Thursday, October 29th. One investment analyst has rated the stock with a Strong Buy rating, twenty have assigned a Buy rating, eight have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $61.43.

View Our Latest Research Report on BSX

Boston Scientific Company Profile

(Free Report)

Boston Scientific is a medical technology company that develops, manufactures and markets devices used in minimally invasive procedures across a range of medical specialties. Founded in 1979, the company is headquartered in Marlborough, Massachusetts. Its products support areas including cardiovascular care, endoscopy, urology and neuromodulation. They include catheter-based devices and therapies for conditions affecting the heart and blood vessels, as well as devices used in diagnostic and therapeutic procedures involving the digestive and urinary systems.

Further Reading

Want to see what other hedge funds are holding BSX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Boston Scientific Corporation (NYSE:BSX – Free Report).

Institutional Ownership by Quarter for Boston Scientific (NYSE:BSX)

Receive News & Ratings for Boston Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Boston Scientific and related companies with MarketBeat.com's FREE daily email newsletter.